114825 Adapalene - CAS 106685-40-9 - Calbiochem

114825
View Pricing & Availability

Overview

Replacement Information

Key Specifications Table

Empirical FormulaCAS #
C₂₈H₂₈O₃ 106685-40-9

Pricing & Availability

Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
114825-25MG
Retrieving availability...
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      25 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity needs to be mulitiple of
      Upon Order Completion More Information
      You Saved ()
       
      Request Pricing
      Description
      OverviewA cell-permeable naphthoic acid compound that exhibits selective affinity and agonistic potency toward RARβ and RARγ over RARα (Kd = 34, 130, and 1100 nM, respectively; AC50 = 2.3, 9.3, and 22 nM, respectively, in COS-7-based reporter assays) without appreciable affinity toward cytosolic retinoic acid binding proteins CRABP I/II (Kd >> 1 µM) or detectable activity toward RXRα (AC50 > 1 µM). The biological activity and pharmaceutical efficacy of ADA are generally shown to be superior to those of ATRA/Tretinoin (Cat. No. 554720) both in vitro and in vivo.
      Catalogue Number114825
      Brand Family Calbiochem®
      SynonymsCD271, RAR Agonist V, ADA, Differin, 6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid, CD 271
      References
      ReferencesIrby, C.E., et al. 2008. J. Adolesc. Health 43, 421.
      Ocker, M., et al. 2003. Int. J. Cancer 107, 453.
      Kim, M.J., et al. 2000. J. Invest. Dermatol. 114, 349.
      Shroot, B., et al. 1997. J. Am. Acad. Dermatol. 36, S96.
      Product Information
      CAS number106685-40-9
      FormWhite solid
      Hill FormulaC₂₈H₂₈O₃
      Chemical formulaC₂₈H₂₈O₃
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥97% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Adapalene - CAS 106685-40-9 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      Adapalene - CAS 106685-40-9 - Calbiochem Certificates of Analysis

      TitleLot Number
      114825

      References

      Reference overview
      Irby, C.E., et al. 2008. J. Adolesc. Health 43, 421.
      Ocker, M., et al. 2003. Int. J. Cancer 107, 453.
      Kim, M.J., et al. 2000. J. Invest. Dermatol. 114, 349.
      Shroot, B., et al. 1997. J. Am. Acad. Dermatol. 36, S96.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision01-September-2010 RFH
      SynonymsCD271, RAR Agonist V, ADA, Differin, 6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid, CD 271
      DescriptionA cell-permeable naphthoic acid compound that exhibits selective affinity and agonistic potency toward RARβ and RARγ over RARα (Kd = 34, 130, and 1100 nM, respectively; AC50 = 2.3, 9.3, and 22 nM, respectively, in COS-7-based reporter assays) without appreciable affinity toward cytosolic retinoic acid binding proteins CRABP I/II (Kd >> 1 µM) or detectable activity toward RXRα (AC50 > 1 µM). The biological activity and pharmaceutical efficacy of ADA are generally shown to be superior to those of ATRA/Tretinoin (Cat. No. 554720) both in vitro and in vivo.
      FormWhite solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number106685-40-9
      Chemical formulaC₂₈H₂₈O₃
      Structure formulaStructure formula
      Purity≥97% by HPLC
      SolubilityDMSO (12 mg/ml)
      Storage +2°C to +8°C
      Protect from light
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Standard Handling
      ReferencesIrby, C.E., et al. 2008. J. Adolesc. Health 43, 421.
      Ocker, M., et al. 2003. Int. J. Cancer 107, 453.
      Kim, M.J., et al. 2000. J. Invest. Dermatol. 114, 349.
      Shroot, B., et al. 1997. J. Am. Acad. Dermatol. 36, S96.

      Related Products & Applications

      Alternative Products

      Catalog Number Description  
      100594 Aluminium Cell Test Show Pricing & Availability

      Related Products

      Catalog Number Description  
      100594 Aluminium Cell Test Show Pricing & Availability

      Accessories (Primary)

      Accessories (Secondary)

      Catalog Number Description  
      100731 Sulfuric acid 95-97% Show Pricing & Availability
      173502 Semi-microcells 50 mm Show Pricing & Availability
      109634 2-Propanol Show Pricing & Availability

      Categories

      Life Science Research > Inhibitors and Biochemicals > Biochemicals > Vitamins, Coenzymes and Cofactors